IL-6-induced skeletal muscle atrophy

Area of Science:

• Biochemistry
• Cell Biology
• Physiology

Background:

• Chronic, low-level elevation of interleukin-6 (IL-6) is linked to aging and disease states.
• Increased IL-6 occurs post-intense exercise and impacts skeletal muscle metabolism and growth.
• Previous research suggests IL-6 has varied roles in skeletal muscle, including potential muscle wasting.

Purpose of the Study:

• To investigate the direct impact of IL-6 on skeletal muscle in vivo.
• To determine IL-6's effects independent of systemic cytokine changes.
• To elucidate the molecular mechanisms underlying IL-6-induced muscle alterations.

Main Methods:

• Utilized a rodent local muscle infusion model to deliver IL-6.
• Measured cellular and molecular markers of cytokine and growth factor signaling.
• Assessed protein content and indicators of muscle atrophy.

Main Results:

• Local IL-6 infusion induced significant muscle atrophy, with a 17% loss of myofibrillar protein.
• IL-6 decreased phosphorylation of ribosomal S6 kinase and STAT5.
• IL-6 increased STAT3 phosphorylation, indicating a shift towards a catabolic signaling profile.

Conclusions:

• Direct IL-6 exposure causes skeletal muscle atrophy.
• IL-6 alters intracellular signaling, favoring catabolic pathways over anabolic ones.
• Downregulation of growth factor signaling may mediate IL-6-induced muscle atrophy.